Browse studies

Find your next paid study

77 recruiting studies matching your filters

ACT to Reduce Morbidity and Mortality in Hematopoietic Stem Cell Transplant (HCT) Patients (ACTivate)

This study is a phase 2, multicenter, randomized controlled trial to test the application of Acceptance and Commitment Therapy (ACT) in HCT patients. ACT is a…

Stem Cell Transplant Patients

Estimated

~$10 – $7,500

Anthony Sung, MDNCT07516314

Phase 1

Antigen Specific Adoptive T Cell Therapy for Opportunistic Cytomegalovirus Infection Occurring After Stem Cell Transplant

The purpose of this study is to determine if a specific type of cell-based immunotherapy, using T-cells from a donor that are specific against cytomegalovirus …

Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantOpportunistic Infections

Estimated

~$10 – $7,500

Mari DallasNCT02982902

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

The primary purpose of the Research Sample Repository is to make blood samples available for research studies related to histocompatibility and hematopoietic c…

Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationCellular Therapy+1 more

Estimated

~$10 – $1,125

Center for International Blood and Marrow Transplant ResearchNCT04920474

Observational

Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopoietic Stem Cell Transplantation (REMM-HIIT-HCT)

The goal of this clinical trial is to learn how a remotely monitored high-intensity interval training (REMM-HIIT) affects the cardiorespiratory fitness and phy…

Hematopoietic Stem Cell TransplantationCardiorespiratory Fitness

Estimated

~$10 – $6,250

University of Kansas Medical CenterNCT06953648

Intestinal Microbiota Alteration by Antibiotics Used During Stem Cell Transplant Admission

In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period…

Stem Cell Transplant Complications

Estimated

~$10 – $750

Henry Ford Health SystemNCT04623424

Phase 2

Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation (ADAPT)

This is a prospective, single-arm, phase II study. Patients will be treated with an allogeneic stem cell transplantation (AHSCT) using fludarabine, melphalan a…

Allogeneic Hematopoietic Stem Cell TransplantationAllogeneic Stem Cell TransplantationHematologic Malignancies

Estimated

~$10 – $6,250

University of California, IrvineNCT06028828

Observational

Development of a Mindfulness-Based Smartphone Application for BMT Caregivers

This pilot study evaluates the feasibility, acceptability, usability, and engagement of a smartphone-delivered mindfulness intervention for caregivers of hemat…

Caregivers of Hematopoietic Stem Cell Transplant (HCT) Patients

Estimated

~$10 – $6,250

H. Lee Moffitt Cancer Center and Research InstituteNCT07352943

Phase 2

A Phase 2 Study of Fludarabine and Intermediate-dose Total Body Irradiation (800 cGy) Followed by Post-transplant Cyclophosphamide in Patients Aged 18-65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies

The Flu-TBI 800 trial is a prospective, single-arm, multicenter, interventional phase 2 study to evaluate whether fludarabine plus intermediate-dose total body…

Allogeneic Stem Cell Transplant Recipient

Estimated

~$10 – $7,500

Hackensack Meridian HealthNCT07214688

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular…

Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationSolid Tumors+4 more

Estimated

~$10 – $1,125

Center for International Blood and Marrow Transplant ResearchNCT01166009

Phase 2

Safety and Immunogenicity of Shingrix Administered to Recipients of Allogeneic Peripheral and Cord Blood Stem Cell Transplants: Effect of Timing of Vaccination After Transplantation

This research is designed to determine if the adjuvanted recombinant glycoprotein E (gE) herpes zoster (HZ) vaccine (Shingrix) has acceptable immunogenicity an…

Bone Marrow TransplantStem Cell Transplant

Estimated

~$10 – $6,250

University of Colorado, DenverNCT05775718

Observational

Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients

Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, U…

ObesityStem Cell Transplant

Estimated

~$10 – $6,250

University of California, Los AngelesNCT04997473

Phase 1

Addition of Venetoclax to Combined Reduced Intensity Hematopoietic Stem Cell and Kidney Transplantation for Patients With Chronic Kidney Disease and Hematologic Malignancy

The primary objective is to assess the safety of the addition of venetoclax to reduced intensity conditioning for HLA-matched and haploidentical combined HSC a…

Kidney Failure ChronicStem Cell TransplantStem Cell Transplant Complications+2 more

Estimated

~$10 – $6,250

Massachusetts General HospitalNCT07358195